Research

Anti-platelet therapy prevents the progression of fatty liver to liver cancer in animal models

A study published in the journal Nature Medicine proposes a paradigm shift in the approach to steatohepatitis, the most advanced degree of non-alcoholic fatty liver disease, one of the diseases responsible for the increase in the incidence of liver cancer.